CD47 and colorectal cancer: Additionally, researchers have used nanoscale metal–organic frameworks (nMOFs) to co-deliver TLR7 and CD47 antibodies to the tumor site and cooperated with PD-L1 immune checkpoint inhibitors to treat colorectal cancer.